Skip to Content
About Abbott
Contact
United States | eng
Country Language
CARDIOVASCULAR
United States | eng
Country Language

CardioMEMS™ HF System: Getting Started Guide

Preparing for Implant Procedure

Home

Living With Heart Failure

The CardioMEMS HF System

Preparing for Implant Procedure

Life Post-Procedure

Resources

Frequently Asked Questions


Once you are identified as an appropriate candidate for the CardioMEMS HF System, you will be scheduled for an implant procedure.

Preparing for the Procedure
Preparing for the Procedure

How do I prepare for the CardioMEMS HF System?

Your care team will discuss any changes you will need to make to your medications and daily routine.

Before the implant, you will be trained on how to take daily pressure readings.

What happens during the procedure?

The CardioMEMS™ PA Sensor is inserted into the pulmonary artery during a right heart catheterization.

  1. You may receive mild sedation to keep you comfortable.
  2. Your doctor will make a small incision and place the catheter into a vein in your neck or groin.
  3. Using an X-ray as a guide, your doctor will insert the catheter to your heart and into your pulmonary artery.
  4. Once the catheter is in the correct position, the sensor is released into the artery, where it remains permanently.
  5. The procedure will take an average of 30-45 minutes and most patients will go home the same day.

As with any medical procedure, there are risks associated with implanting the device, although complications are very rare.1

CardioMEMS Sensor

Watch an overview of the CardioMEMS HF System implant procedure

After the procedure, you may have mild pain or bruising at the incision site for a couple of days, but you should be able to resume normal activities soon afterwards.

  • You will not feel the sensor in your pulmonay artery
  • Since the sensor doesn't contain any batteries, it won't need to be replaced and won't need to be charged
  • Your sensor won't interfere with daily activities or other implanted devices like pacemakers or defibrillators2

Implantation of the CardioMEMS PA Sensor is a safe, proven, common procedure.

In clinical studies of heart failure patients, hemodynamic monitoring with the CardioMEMS HF System led to:
 

quality of life

Significant improvement in quality of life1

57%

57% Reduction in heart failure hospitalizations3

Improved survival

Improved survival in heart failure patients4-6

Summary

Summary Checkmark

• Insertion of the CardioMEMS PA Sensor via RHC is a safe, proven, and commonly performed procedure.

 

• You will not feel the sensor, nor will it interfere with any of your other devices.2

 

• Your care team will use the CardioMEMS HF System data to proactively treat your heart failure to keep you out of the hospital.

PREVIOUS
BACK TO TOP
NEXT

These materials are not intended to replace your doctor's advice or information. For any questions or concerns you may have regarding the medical procedures, devices and/or your personal health, please discuss these with your physicians.


References

  1. Brugts JJ, Radhoe SP, Clephas PRD, et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial [published correction appears in Lancet. 2023 Jun 24;401(10394):2112. doi: 10.1016/S0140-6736(23)01256-4.]. Lancet. 2023;401(10394):2113-2123. doi:10.1016/S0140-6736(23)00923-6
  2. Abbott data on file.
  3. Shavelle D, Desai A, Abraham W, et al. Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure. Circulation: Heart Failure. 2020;13(8):229-238.
  4. Givertz MM, Stevenson LW, Costanzo MR, et al., on behalf of the CHAMPION Trial Investigators. Pulmonary artery pressure–guided management of patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70:1875-86.
  5. Abraham J, et al. Association of Ambulatory Hemodynamic Monitoring with Clinical Outcomes in a Concurrent Matched Cohort Analysis. JAMA Cardiology. 2019;4(6):556-563.
  6. Lindenfeld, J, Costanzo, M, Zile, M. et al. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2024 Feb, 83 (6) 682–694. https://doi.org/10.1016/j.jacc.2023.11.030.

MAT-2400392 v2.0

CARDIOMEMS HF SYSTEM
GETTING STARTED GUIDE
OTHER RESOURCES
abbott logo

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2025 Abbott. All Rights Reserved.

MAT-2400380 v5.0